4-Bromo-N-(dimethyloxido-λ4-sulfanylidene)-benzenamine
CAS: 56158-10-2
Ref. 3D-GCA15810
25mg | 294.00 € | ||
250mg | 1,101.00 € |
Product Information
4-Bromo-N-(dimethyloxido-λ4-sulfanylidene)benzenamine is a pandemic influenza drug that has been shown to have antiviral activity against the H1N1 virus. Covid-19, the active ingredient in 4-Bromo-N-(dimethyloxido-λ4-sulfanylidene)benzenamine, is a nucleoside analog that inhibits viral replication by blocking the interaction between viral RNA polymerase and host cell ribosomes. Covid-19 has been shown to be effective against laboratory strains of H1N1 and H3N2 influenza A viruses and is currently undergoing clinical trials. Covid-19 also has antiviral activity against other respiratory viruses such as SARS coronavirus and human metapneumovirus.
Chemical properties
Technical inquiry about: 3D-GCA15810 4-Bromo-N-(dimethyloxido-λ4-sulfanylidene)-benzenamine
If you want to request a quotation or place an order, please instead add the desired products to your cart and then request a quotation or order from the cart. It is faster, cheaper, and you will be able to benefit from the available discounts and other advantages.